Review



anti vegfr2  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems anti vegfr2
    Anti Vegfr2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 205 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti vegfr2/product/R&D Systems
    Average 94 stars, based on 205 article reviews
    anti vegfr2 - by Bioz Stars, 2026-03
    94/100 stars

    Images



    Similar Products

    99
    Bio-Techne corporation mouse vegfr2/kdr/flk-1 antibody
    Mouse Vegfr2/Kdr/Flk 1 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse vegfr2/kdr/flk-1 antibody/product/Bio-Techne corporation
    Average 99 stars, based on 1 article reviews
    mouse vegfr2/kdr/flk-1 antibody - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec kdr
    Cardiac Organoids. (A) Schematic representation of the cardiac organoid differentiation protocol displaying experimental timing, cell culture media as well as small molecules and cytokines used to induce cardiac tissue. The image was created in BioRender (Wörsdörfer, P. (2025) https://BioRender.com/rz8x29g ). (B) Semiquantitative RT-PCR detecting mesodermal ( TBXT , <t>KDR</t> , GATA4 , RUNX1 ), cardiac ( NKX2.5 , TBX5 , ISL1 , TNNT2 , DES , RYR2 ), and endothelial <t>(</t> <t>PECAM1</t> ) marker gene expression at days 2, 4 and 8 of differentiation. (C) H&E staining of an organoid section at day 2. (D,D′) Immunofluorescence analysis of the organoid shown in C detecting early mesodermal markers TBXT and VIM at day 2 of organoid development. (E) Immunofluorescence analysis of the organoid shown in C detecting early mesodermal markers GATA6 and KDR at day 2 of organoid development. (F) H&E staining showing hollow cavity-like structures in cardiac organoids at day 7. (G,G′) Immunofluorescence analysis of the organoid shown in F detecting mesenchymal cells (VIM + ) in close association with cardiomyocytes (TNNT2 + ) at day 7 of organoid development. (H) H&E staining of organoid sections at day 35 of development. (I) Immunofluorescence analysis of the organoid shown in H showing close interaction of fibroblasts (VIM + ) and cardiomyocytes (TNNT2 + ) at day 35 of organoid development. (J) Cardiac organoids progressively increase in size (day 0 = 712.2 ± 6.8 µm, n = 72; day 7 = 1,231 ± 20.3 µm, n = 70; day 25 = 1,613 ± 45.4 µm, n = 41. ***p < 0.001, ****p < 0.0001. (K) Contraction frequency of organoids increases over time, from 25 ± 1.9 bpm at day 7–57 ± 10.5 bpm at day 35 (n = 8). **p < 0.01, ****p < 0.0001.
    Kdr, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/kdr/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    kdr - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    95
    Proteintech anti mouse kdr
    Cardiac Organoids. (A) Schematic representation of the cardiac organoid differentiation protocol displaying experimental timing, cell culture media as well as small molecules and cytokines used to induce cardiac tissue. The image was created in BioRender (Wörsdörfer, P. (2025) https://BioRender.com/rz8x29g ). (B) Semiquantitative RT-PCR detecting mesodermal ( TBXT , <t>KDR</t> , GATA4 , RUNX1 ), cardiac ( NKX2.5 , TBX5 , ISL1 , TNNT2 , DES , RYR2 ), and endothelial <t>(</t> <t>PECAM1</t> ) marker gene expression at days 2, 4 and 8 of differentiation. (C) H&E staining of an organoid section at day 2. (D,D′) Immunofluorescence analysis of the organoid shown in C detecting early mesodermal markers TBXT and VIM at day 2 of organoid development. (E) Immunofluorescence analysis of the organoid shown in C detecting early mesodermal markers GATA6 and KDR at day 2 of organoid development. (F) H&E staining showing hollow cavity-like structures in cardiac organoids at day 7. (G,G′) Immunofluorescence analysis of the organoid shown in F detecting mesenchymal cells (VIM + ) in close association with cardiomyocytes (TNNT2 + ) at day 7 of organoid development. (H) H&E staining of organoid sections at day 35 of development. (I) Immunofluorescence analysis of the organoid shown in H showing close interaction of fibroblasts (VIM + ) and cardiomyocytes (TNNT2 + ) at day 35 of organoid development. (J) Cardiac organoids progressively increase in size (day 0 = 712.2 ± 6.8 µm, n = 72; day 7 = 1,231 ± 20.3 µm, n = 70; day 25 = 1,613 ± 45.4 µm, n = 41. ***p < 0.001, ****p < 0.0001. (K) Contraction frequency of organoids increases over time, from 25 ± 1.9 bpm at day 7–57 ± 10.5 bpm at day 35 (n = 8). **p < 0.01, ****p < 0.0001.
    Anti Mouse Kdr, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti mouse kdr/product/Proteintech
    Average 95 stars, based on 1 article reviews
    anti mouse kdr - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec kdr cd309 apc
    Cardiac Organoids. (A) Schematic representation of the cardiac organoid differentiation protocol displaying experimental timing, cell culture media as well as small molecules and cytokines used to induce cardiac tissue. The image was created in BioRender (Wörsdörfer, P. (2025) https://BioRender.com/rz8x29g ). (B) Semiquantitative RT-PCR detecting mesodermal ( TBXT , <t>KDR</t> , GATA4 , RUNX1 ), cardiac ( NKX2.5 , TBX5 , ISL1 , TNNT2 , DES , RYR2 ), and endothelial <t>(</t> <t>PECAM1</t> ) marker gene expression at days 2, 4 and 8 of differentiation. (C) H&E staining of an organoid section at day 2. (D,D′) Immunofluorescence analysis of the organoid shown in C detecting early mesodermal markers TBXT and VIM at day 2 of organoid development. (E) Immunofluorescence analysis of the organoid shown in C detecting early mesodermal markers GATA6 and KDR at day 2 of organoid development. (F) H&E staining showing hollow cavity-like structures in cardiac organoids at day 7. (G,G′) Immunofluorescence analysis of the organoid shown in F detecting mesenchymal cells (VIM + ) in close association with cardiomyocytes (TNNT2 + ) at day 7 of organoid development. (H) H&E staining of organoid sections at day 35 of development. (I) Immunofluorescence analysis of the organoid shown in H showing close interaction of fibroblasts (VIM + ) and cardiomyocytes (TNNT2 + ) at day 35 of organoid development. (J) Cardiac organoids progressively increase in size (day 0 = 712.2 ± 6.8 µm, n = 72; day 7 = 1,231 ± 20.3 µm, n = 70; day 25 = 1,613 ± 45.4 µm, n = 41. ***p < 0.001, ****p < 0.0001. (K) Contraction frequency of organoids increases over time, from 25 ± 1.9 bpm at day 7–57 ± 10.5 bpm at day 35 (n = 8). **p < 0.01, ****p < 0.0001.
    Kdr Cd309 Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/kdr cd309 apc/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    kdr cd309 apc - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    90
    r&d systems mouse vegfr2/kdr/flk-1 antibody (1: 200)

    Mouse Vegfr2/Kdr/Flk 1 Antibody (1: 200), supplied by r&d systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse vegfr2/kdr/flk-1 antibody (1: 200)/product/r&d systems
    Average 90 stars, based on 1 article reviews
    mouse vegfr2/kdr/flk-1 antibody (1: 200) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    94
    R&D Systems anti vegfr2

    Anti Vegfr2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti vegfr2/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    anti vegfr2 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    R&D Systems goat anti mouse kdr

    Goat Anti Mouse Kdr, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat anti mouse kdr/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    goat anti mouse kdr - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    R&D Systems goat anti vegfr2
    a , b , High-resolution confocal images showing EMCN + VEGFR3 − rECs (arrowheads) around TB in relation to RUNX2 + osteoprogenitors (green) ( a ) and ATP6V1B1/B2 + osteoclasts (green) ( b ). c , d , Maximum-intensity projection showing Sp7-mCherry + osteoblasts (yellow) and ATP6V1B1/B2 + osteoclasts (green) in in relation to EMCN + VEGFR3 − rECs around 6-week-old femoral TB ( c ). Single xy plane ( d ). Green arrowheads mark rECs near osteoclasts and yellow arrowheads near osteoblasts. e , f , Distribution of EMCN + VEGFR3 − type R vessels in relation to Sp7-mCherry + osteoblasts (yellow arrowheads) and ATP6V1B1/B2 + osteoclasts (green arrowheads) around 6-week-old and 12-week-old TB ( e ). Isolated xy plane ( f ). g , Confocal images showing VEGFR3 − <t>VEGFR2</t> + ECs (white arrowheads) around TB in young and aged patient samples. VEGFR3 (yellow), VEGFR2 (red) and nuclei (DAPI, blue). DAPI, 4,6-diamidino-2-phenylindole.
    Goat Anti Vegfr2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat anti vegfr2/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    goat anti vegfr2 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec antibody cd309 vegfr 2 kdr mouse miltenyi
    a , b , High-resolution confocal images showing EMCN + VEGFR3 − rECs (arrowheads) around TB in relation to RUNX2 + osteoprogenitors (green) ( a ) and ATP6V1B1/B2 + osteoclasts (green) ( b ). c , d , Maximum-intensity projection showing Sp7-mCherry + osteoblasts (yellow) and ATP6V1B1/B2 + osteoclasts (green) in in relation to EMCN + VEGFR3 − rECs around 6-week-old femoral TB ( c ). Single xy plane ( d ). Green arrowheads mark rECs near osteoclasts and yellow arrowheads near osteoblasts. e , f , Distribution of EMCN + VEGFR3 − type R vessels in relation to Sp7-mCherry + osteoblasts (yellow arrowheads) and ATP6V1B1/B2 + osteoclasts (green arrowheads) around 6-week-old and 12-week-old TB ( e ). Isolated xy plane ( f ). g , Confocal images showing VEGFR3 − <t>VEGFR2</t> + ECs (white arrowheads) around TB in young and aged patient samples. VEGFR3 (yellow), VEGFR2 (red) and nuclei (DAPI, blue). DAPI, 4,6-diamidino-2-phenylindole.
    Antibody Cd309 Vegfr 2 Kdr Mouse Miltenyi, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody cd309 vegfr 2 kdr mouse miltenyi/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    antibody cd309 vegfr 2 kdr mouse miltenyi - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    Image Search Results


    Cardiac Organoids. (A) Schematic representation of the cardiac organoid differentiation protocol displaying experimental timing, cell culture media as well as small molecules and cytokines used to induce cardiac tissue. The image was created in BioRender (Wörsdörfer, P. (2025) https://BioRender.com/rz8x29g ). (B) Semiquantitative RT-PCR detecting mesodermal ( TBXT , KDR , GATA4 , RUNX1 ), cardiac ( NKX2.5 , TBX5 , ISL1 , TNNT2 , DES , RYR2 ), and endothelial ( PECAM1 ) marker gene expression at days 2, 4 and 8 of differentiation. (C) H&E staining of an organoid section at day 2. (D,D′) Immunofluorescence analysis of the organoid shown in C detecting early mesodermal markers TBXT and VIM at day 2 of organoid development. (E) Immunofluorescence analysis of the organoid shown in C detecting early mesodermal markers GATA6 and KDR at day 2 of organoid development. (F) H&E staining showing hollow cavity-like structures in cardiac organoids at day 7. (G,G′) Immunofluorescence analysis of the organoid shown in F detecting mesenchymal cells (VIM + ) in close association with cardiomyocytes (TNNT2 + ) at day 7 of organoid development. (H) H&E staining of organoid sections at day 35 of development. (I) Immunofluorescence analysis of the organoid shown in H showing close interaction of fibroblasts (VIM + ) and cardiomyocytes (TNNT2 + ) at day 35 of organoid development. (J) Cardiac organoids progressively increase in size (day 0 = 712.2 ± 6.8 µm, n = 72; day 7 = 1,231 ± 20.3 µm, n = 70; day 25 = 1,613 ± 45.4 µm, n = 41. ***p < 0.001, ****p < 0.0001. (K) Contraction frequency of organoids increases over time, from 25 ± 1.9 bpm at day 7–57 ± 10.5 bpm at day 35 (n = 8). **p < 0.01, ****p < 0.0001.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: Tissue-resident macrophages co-develop with myocardial tissue in human induced pluripotent stem cell-derived organoids

    doi: 10.3389/fcell.2025.1629988

    Figure Lengend Snippet: Cardiac Organoids. (A) Schematic representation of the cardiac organoid differentiation protocol displaying experimental timing, cell culture media as well as small molecules and cytokines used to induce cardiac tissue. The image was created in BioRender (Wörsdörfer, P. (2025) https://BioRender.com/rz8x29g ). (B) Semiquantitative RT-PCR detecting mesodermal ( TBXT , KDR , GATA4 , RUNX1 ), cardiac ( NKX2.5 , TBX5 , ISL1 , TNNT2 , DES , RYR2 ), and endothelial ( PECAM1 ) marker gene expression at days 2, 4 and 8 of differentiation. (C) H&E staining of an organoid section at day 2. (D,D′) Immunofluorescence analysis of the organoid shown in C detecting early mesodermal markers TBXT and VIM at day 2 of organoid development. (E) Immunofluorescence analysis of the organoid shown in C detecting early mesodermal markers GATA6 and KDR at day 2 of organoid development. (F) H&E staining showing hollow cavity-like structures in cardiac organoids at day 7. (G,G′) Immunofluorescence analysis of the organoid shown in F detecting mesenchymal cells (VIM + ) in close association with cardiomyocytes (TNNT2 + ) at day 7 of organoid development. (H) H&E staining of organoid sections at day 35 of development. (I) Immunofluorescence analysis of the organoid shown in H showing close interaction of fibroblasts (VIM + ) and cardiomyocytes (TNNT2 + ) at day 35 of organoid development. (J) Cardiac organoids progressively increase in size (day 0 = 712.2 ± 6.8 µm, n = 72; day 7 = 1,231 ± 20.3 µm, n = 70; day 25 = 1,613 ± 45.4 µm, n = 41. ***p < 0.001, ****p < 0.0001. (K) Contraction frequency of organoids increases over time, from 25 ± 1.9 bpm at day 7–57 ± 10.5 bpm at day 35 (n = 8). **p < 0.01, ****p < 0.0001.

    Article Snippet: Primary antibodies against PECAM1 (CD31) (DAKO, M0823), VIM (Invitrogen, MA5-16409), ACTN1 (Abcam, Ab68167), KDR (Miltenyi Biotec, 130-125-988), TBXT (R&D Systems, AF2085), TNNT2 (Life Technologies, MA512960 ), CD34 (Life Technologies, MA5-32059), AIF1 (WAKO/Fuji Film, 019-19741) and PTPRC (CD45) (Life Technologies, 14-0451-82) were diluted in NBS blocking solution and incubated overnight at 4 °C.

    Techniques: Cell Culture, Reverse Transcription Polymerase Chain Reaction, Marker, Gene Expression, Staining, Immunofluorescence

    Journal: STAR Protocols

    Article Title: Protocol for inducing beige adipocytes in white adipose tissue of mouse using cold exposure and CL316,243 injection

    doi: 10.1016/j.xpro.2024.103337

    Figure Lengend Snippet:

    Article Snippet: Mouse VEGFR2/KDR/Flk-1 antibody (1: 200) , R&D Systems , Catalog # AF644, RRID: AB_355500.

    Techniques: Recombinant, Avidin-Biotin Assay, Blocking Assay, Protease Inhibitor, Bicinchoninic Acid Protein Assay, Reverse Transcription, Software, Microscopy

    a , b , High-resolution confocal images showing EMCN + VEGFR3 − rECs (arrowheads) around TB in relation to RUNX2 + osteoprogenitors (green) ( a ) and ATP6V1B1/B2 + osteoclasts (green) ( b ). c , d , Maximum-intensity projection showing Sp7-mCherry + osteoblasts (yellow) and ATP6V1B1/B2 + osteoclasts (green) in in relation to EMCN + VEGFR3 − rECs around 6-week-old femoral TB ( c ). Single xy plane ( d ). Green arrowheads mark rECs near osteoclasts and yellow arrowheads near osteoblasts. e , f , Distribution of EMCN + VEGFR3 − type R vessels in relation to Sp7-mCherry + osteoblasts (yellow arrowheads) and ATP6V1B1/B2 + osteoclasts (green arrowheads) around 6-week-old and 12-week-old TB ( e ). Isolated xy plane ( f ). g , Confocal images showing VEGFR3 − VEGFR2 + ECs (white arrowheads) around TB in young and aged patient samples. VEGFR3 (yellow), VEGFR2 (red) and nuclei (DAPI, blue). DAPI, 4,6-diamidino-2-phenylindole.

    Journal: Nature Cell Biology

    Article Title: Specialized post-arterial capillaries facilitate adult bone remodelling

    doi: 10.1038/s41556-024-01545-1

    Figure Lengend Snippet: a , b , High-resolution confocal images showing EMCN + VEGFR3 − rECs (arrowheads) around TB in relation to RUNX2 + osteoprogenitors (green) ( a ) and ATP6V1B1/B2 + osteoclasts (green) ( b ). c , d , Maximum-intensity projection showing Sp7-mCherry + osteoblasts (yellow) and ATP6V1B1/B2 + osteoclasts (green) in in relation to EMCN + VEGFR3 − rECs around 6-week-old femoral TB ( c ). Single xy plane ( d ). Green arrowheads mark rECs near osteoclasts and yellow arrowheads near osteoblasts. e , f , Distribution of EMCN + VEGFR3 − type R vessels in relation to Sp7-mCherry + osteoblasts (yellow arrowheads) and ATP6V1B1/B2 + osteoclasts (green arrowheads) around 6-week-old and 12-week-old TB ( e ). Isolated xy plane ( f ). g , Confocal images showing VEGFR3 − VEGFR2 + ECs (white arrowheads) around TB in young and aged patient samples. VEGFR3 (yellow), VEGFR2 (red) and nuclei (DAPI, blue). DAPI, 4,6-diamidino-2-phenylindole.

    Article Snippet: Tissues were incubated with primary antibodies rabbit anti-DACH1 (Proteintech, 10914-1-AP, 1:500 dilution), goat anti-VEGFR2 (R&D Systems, AF644; 1:100 dilution) followed by secondary antibodies anti-rabbit Alexa-488 (Thermo Fisher Scientific, A21206; 1:300 dilution) and anti-goat Alexa-594 (Thermo Fisher Scientific, A11058; 1:300 dilution) overnight on a rotating platform at 4 °C, incubated and mounted with Histodenz (Sigma, D2158) in DAPI.

    Techniques: Isolation

    a, b . High-resolution confocal images showing VEGFR3 (yellow) and VEGFR2 (red) immunostaining together with DAPI (blue). VEGFR3 − VEGFR2 + capillaries (white arrowheads) around trabecular bone (TB) and nearby VEGFR3 + VEGFR2 + vessels (yellow arrowheads) in samples from young ( a ) and aged patients ( b ) are indicated. Scale bars, 200μm. c . Tile scan confocal images of EMCN + VEGFR3 − ECs in 12-week-old female and male murine femur. Trabecular bone (TB) is indicated. Scale bars, 500μm. d . Quantitation of EMCN + VEGFR3 − vessel density in 12-week-old female and male femur (n =3 mice per group). Mean ± SEM. P values, unpaired two-tailed t-test. e . EMCN (red) and VEGFR3 (blue) immunostaining showing the presence of VEGFR3 − EMCN + vessels (white arrowheads) around trabecular bone (TB) in female and male femur. Scale bars, 100μm.

    Journal: Nature Cell Biology

    Article Title: Specialized post-arterial capillaries facilitate adult bone remodelling

    doi: 10.1038/s41556-024-01545-1

    Figure Lengend Snippet: a, b . High-resolution confocal images showing VEGFR3 (yellow) and VEGFR2 (red) immunostaining together with DAPI (blue). VEGFR3 − VEGFR2 + capillaries (white arrowheads) around trabecular bone (TB) and nearby VEGFR3 + VEGFR2 + vessels (yellow arrowheads) in samples from young ( a ) and aged patients ( b ) are indicated. Scale bars, 200μm. c . Tile scan confocal images of EMCN + VEGFR3 − ECs in 12-week-old female and male murine femur. Trabecular bone (TB) is indicated. Scale bars, 500μm. d . Quantitation of EMCN + VEGFR3 − vessel density in 12-week-old female and male femur (n =3 mice per group). Mean ± SEM. P values, unpaired two-tailed t-test. e . EMCN (red) and VEGFR3 (blue) immunostaining showing the presence of VEGFR3 − EMCN + vessels (white arrowheads) around trabecular bone (TB) in female and male femur. Scale bars, 100μm.

    Article Snippet: Tissues were incubated with primary antibodies rabbit anti-DACH1 (Proteintech, 10914-1-AP, 1:500 dilution), goat anti-VEGFR2 (R&D Systems, AF644; 1:100 dilution) followed by secondary antibodies anti-rabbit Alexa-488 (Thermo Fisher Scientific, A21206; 1:300 dilution) and anti-goat Alexa-594 (Thermo Fisher Scientific, A11058; 1:300 dilution) overnight on a rotating platform at 4 °C, incubated and mounted with Histodenz (Sigma, D2158) in DAPI.

    Techniques: Immunostaining, Quantitation Assay, Two Tailed Test

    a , t -SNE visualization of Dach1 gene expression in ECs of different organs. b , Confocal tile scan overview images of 12-week-old Dach1 iΔEC and control retina stained for CD31 (red). Scale bars, 300μm. c , Quantitation of CD31 + vessel density in 12-week-old Dach1 iΔEC retinas relative to control (n =4 mice per group). Mean ± SEM. P values, unpaired two-tailed t-test. d , High-resolution confocal images of Dach1 iΔEC and control intestinal villi stained for DACH1 (green), VEGFR2 (red), and DAPI (blue). Scale bars, 50μm and insets 15μm. e , Quantitation of average VEGFR2 + vessel density, villus size, and average vascular area per villus in 12-week-old Dach1 iΔEC and littermate control (n =4 mice per group). Mean ± SEM. P values, unpaired two-tailed t-test. f , Confocal tile scan overview images of 12-week-old female Dach1 iΔEC and control femur stained for EMCN (red) and OSTERIX (green, OSX). White dashed lines and yellow arrowheads indicate reduction of region containing trabecular bone (TB) in Dach1 iΔEC mutants. Scale bars, 500μm. g . High-magnification images showing EMCN (red) and ATP6V1B1/B2 (green) immunostained female Dach1 iΔEC and control femur. Growth plate (GP) is indicated. Scale bars, 100μm. h . Quantitation of OSX + cells and ATPV6B1B2 area in control and Dach1 iΔEC mutant (n=3 and 4 mice per group). Mean ± SEM. P values, unpaired two-tailed t-test. i . Quantitation shows connectivity density and cortical thickness (per mm), (n = 3-4 female mice per group and n=3 male mice per group). Mean ± SEM. P values, plotted using unpaired two-tailed t-test. j . DACH1 (green) co-stained with VE-CADHERIN (red) in siCONTROL and siDACH1 cultured HUVECs. k . Downregulation of arterial marker genes in siDACH1 HUVECs relative to siCONTROL . n=6 (3 independent experiments) for each group. Mean ± SEM. P values, unpaired two-tailed t-test with Welch’s correction.

    Journal: Nature Cell Biology

    Article Title: Specialized post-arterial capillaries facilitate adult bone remodelling

    doi: 10.1038/s41556-024-01545-1

    Figure Lengend Snippet: a , t -SNE visualization of Dach1 gene expression in ECs of different organs. b , Confocal tile scan overview images of 12-week-old Dach1 iΔEC and control retina stained for CD31 (red). Scale bars, 300μm. c , Quantitation of CD31 + vessel density in 12-week-old Dach1 iΔEC retinas relative to control (n =4 mice per group). Mean ± SEM. P values, unpaired two-tailed t-test. d , High-resolution confocal images of Dach1 iΔEC and control intestinal villi stained for DACH1 (green), VEGFR2 (red), and DAPI (blue). Scale bars, 50μm and insets 15μm. e , Quantitation of average VEGFR2 + vessel density, villus size, and average vascular area per villus in 12-week-old Dach1 iΔEC and littermate control (n =4 mice per group). Mean ± SEM. P values, unpaired two-tailed t-test. f , Confocal tile scan overview images of 12-week-old female Dach1 iΔEC and control femur stained for EMCN (red) and OSTERIX (green, OSX). White dashed lines and yellow arrowheads indicate reduction of region containing trabecular bone (TB) in Dach1 iΔEC mutants. Scale bars, 500μm. g . High-magnification images showing EMCN (red) and ATP6V1B1/B2 (green) immunostained female Dach1 iΔEC and control femur. Growth plate (GP) is indicated. Scale bars, 100μm. h . Quantitation of OSX + cells and ATPV6B1B2 area in control and Dach1 iΔEC mutant (n=3 and 4 mice per group). Mean ± SEM. P values, unpaired two-tailed t-test. i . Quantitation shows connectivity density and cortical thickness (per mm), (n = 3-4 female mice per group and n=3 male mice per group). Mean ± SEM. P values, plotted using unpaired two-tailed t-test. j . DACH1 (green) co-stained with VE-CADHERIN (red) in siCONTROL and siDACH1 cultured HUVECs. k . Downregulation of arterial marker genes in siDACH1 HUVECs relative to siCONTROL . n=6 (3 independent experiments) for each group. Mean ± SEM. P values, unpaired two-tailed t-test with Welch’s correction.

    Article Snippet: Tissues were incubated with primary antibodies rabbit anti-DACH1 (Proteintech, 10914-1-AP, 1:500 dilution), goat anti-VEGFR2 (R&D Systems, AF644; 1:100 dilution) followed by secondary antibodies anti-rabbit Alexa-488 (Thermo Fisher Scientific, A21206; 1:300 dilution) and anti-goat Alexa-594 (Thermo Fisher Scientific, A11058; 1:300 dilution) overnight on a rotating platform at 4 °C, incubated and mounted with Histodenz (Sigma, D2158) in DAPI.

    Techniques: Expressing, Control, Staining, Quantitation Assay, Two Tailed Test, Mutagenesis, Cell Culture, Marker